Edward M. Kaye MD - 27 Mar 2023 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role: CEO, Director
Signature: /s/ Stephen Tulipano, Attorney-in-Fact
Issuer symbol: STOK
Transactions as of: 27 Mar 2023
Net transactions value: +$12,000
Form type: 4
Filing time: 08 Sep 2023, 16:15:39 UTC
Previous filing: 17 Mar 2023
Next filing: 05 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STOK	Common Stock	Options Exercise	$12,000	+20,000	+80%	$0.6000^*	45,000	27 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STOK	Employee Stock Option (right to buy)	Options Exercise	$0	-20,000	-3.2%	$0.000000	602,801	27 Mar 2023	Common Stock	20,000	$0.6000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested as to 1/4th of the total shares on October 17, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.